APR Applied Pharma Research S.A. and Labtec GmbH Enter Into Exclusive Licensing Agreement With Ferrer Internacional for the Registration and Marketing of Donepezil Oral Dispersible Film in Spain, Portugal and Germany

Published: Oct 01, 2010

BALERNA, Switzerland & BARCELONA, Spain--(BUSINESS WIRE)--APR and its development partner Labtec have entered into an exclusive licensing agreement with the leading European pharmaceutical company Ferrer Internacional (Ferrer) for the promotion, distribution and marketing of Donepezil Oral Dispersible Film (ODF) in Spain, Portugal and Germany. Terms of the deal were not disclosed.

Back to news